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SUMMARY
Receptor interacting protein kinase 3 (RIPK3) induces
necroptosis, a type of regulated necrosis, through
its kinase domain and receptor interacting protein
(RIP) homotypic interaction motif (RHIM). In addition,
RIPK3 has been shown to regulate NLRP3 inflamma-
some and nuclear factor kB (NF-kB) activation. How-
ever, the relative contribution of these signaling path-
ways to RIPK3-dependent inflammation in distinct
immune effectors is unknown. To investigate these
questions, we generated RIPK3-GFP reporter mice.
We found that colonic CD11c+CD11b+CD14+ mono-
nuclear phagocytes (MNPs) expressed the highest
level of RIPK3 in the lamina propria. Consequently,
deletion of the RIPK3 RHIM in CD11c+ cells alone
was sufficient to impair dextran sodium sulfate
(DSS)-induced interleukin (IL)-23 and IL-1b expres-
sion, leading to severe intestinal inflammation. In
contrast, mice expressing kinase inactive RIPK3
were not hypersensitive to DSS. Thus, a key physio-
logical function of RIPK3 is to promote reparative
cytokine expression through intestinal CD11c+ MNPs
in a kinase- and necroptosis-independent manner.
INTRODUCTION
Necroptosis is a typeof regulatednecrosis inducedbyseveral cell
surface immune receptors suchas tumornecrosis factor (TNF) re-
ceptor (TNFR), Toll-like receptor (TLR) 3 (TLR3), TLR4, interferon
receptor, and T cell receptor (Chan et al., 2015). Receptor inter-
acting protein kinase 3 (RIPK3) is a cytosolic master regulator
of necroptosis (Moriwaki and Chan, 2013). RIPK3 has an active
serine-threonine kinase domain at the N terminus and a unique
protein-protein interaction domain called the RIP homotypic
interaction motif (RHIM) at the C terminus. Both kinase activity
and RHIM are indispensable for necroptosis (Cho et al., 2009).
RIPK3 interacts with other RHIM-containing proteins such as
RIPK1 (Cho et al., 2009; He et al., 2009), Toll/interleukin-1 (IL-1)
receptor domain-containing adaptor protein inducing interferon
b (TRIF) (Heet al., 2011), orDNA-dependent activator of interferon
regulatory factor (DAI) (Upton et al., 2012). RHIM-RHIM interac-
tion leads to amyloid-like conformational change and enhance-
ment of RIPK3 kinase activity (Li et al., 2012). Activated RIPK3
phosphorylates the downstream adaptor MLKL (Sun et al.,
2012), which triggers oligomerization and translocation of MLKL
to the plasmamembrane (Cai et al., 2014; Chen et al., 2014; Don-
delinger et al., 2014; Wang et al., 2014).
Besides necroptosis, recent emerging evidence shows that
RIPK3 also has necroptosis-independent functions (Moriwaki
and Chan, 2014). For example, RIPK3 stimulates nuclear factor
kB (NF-kB)-dependent Il23p19 (Il23a) expression and pro-IL-1b
processing downstream of TLR4 in bone marrow (BM)-derived
dendritic cells (DCs) (BMDCs) (Moriwaki et al., 2014). Similar
RIPK3-dependent processing of pro-IL-1b has also been
observed in BM-derived macrophages (BMDMs) treated with
Smac mimetics and/or caspase inhibitors (Kang et al., 2013,
2015; Lawlor et al., 2015; Vince et al., 2012). However, the rela-
tive contribution of necroptosis-dependent and -independent
effects of RIPK3 in physiological inflammation has not been
clearly elucidated.
Germline Ripk3-deficient mice have been used extensively to
investigate the pathophysiological roles of RIPK3 (Chan et al.,
2015). The resolution of inflammation in Ripk3/ mice has often
been attributed as a consequence of blocking necroptosis. Strik-
ingly, RIPK3 has recently been shown to have paradoxical func-
tion in promoting injury-induced tissue repair (Godwin et al.,
2015). In a mouse model of chemical-induced intestinal injury,
RIPK3 facilitates expression of IL-23 and IL-1b, which in turn
stimulates expression of the tissue repair cytokine IL-22. Thus,
Ripk3/ mice developed sustained injury and inflammation
(Moriwaki et al., 2014, 2016). Based on these results, we asked
whether RIPK3 promotes cytokine-induced tissue repair mainly
through DCs. To achieve our goal, we generated ‘‘knock-in’’
mice expressing an RIPK3-GFP fusion reporter, as well as mice
with tissue-specific deletion of the essential RHIM (Ripk3DR/DR).
Using the RIPK3-GFP reporter mice, we found that RIPK3 was
highly expressed in intestinal CD11c+CD11b+CD14+CD103
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mononuclear phagocytes (MNPs). Deletion of RIPK3 RHIM in
CD11c+ cells fully recapitulated the severe intestinal inflamma-
tion observed in germlineRipk3/mice. In contrast, kinase inac-
tive RIPK3 knock-in mice did not exhibit hypersensitivity in
response to chemical-induced colitis. Collectively, these results
reveal cell-type-specific functions of RIPK3 in inflammation as
well as the importance of RHIM-RHIM-mediated interaction in
biological responses beyond necroptosis.
RESULTS
Generation of RIPK3-GFP Reporter Mice
RIPK3 expression is often induced in tissues and cells during
inflammation (Gautheron et al., 2014; Moriwaki et al., 2014; Vitner
et al., 2014). To determine the physiological expression pattern of
RIPK3 inquiescentand inflamedstates,wegeneratedRIPK3-GFP
reportermice inwhich theRipk3 genewas fused in-framewith the
eGfp sequence at the end of the RIPK3 translated sequence (Fig-
ure S1A). Proper targeting of the Ripk3 locus was confirmed by
Southern blot analysis (Figures S1A–S1C). We confirmed that
RIPK3-GFP and wild-type RIPK3 were expressed at similar levels
in Ripk3-gfpfl/+ mouse embryonic fibroblasts (MEFs) (Figure 1A).
The percentage and number of T and B cells in the thymus and
lymph node were normal in Ripk3+/+ and Ripk3-gfpfl/fl mice (Fig-
ures S1D and S1E and data not shown). In addition, the composi-
tion of BM cells was unchanged inRipk3-gfpfl/flmice (Figure S1F).
Hence, the RIPK3-GFP fusion protein faithfully reports in vivo
expression of RIPK3 without disrupting RIPK3 function.
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Figure 1. RIPK3 Is Highly Expressed in Colonic CD11c+CD11b+CD103 MNPs
(A) RIPK3-GFP and RIPK3 expression in MEFs of the indicated genotypes were examined by western blot.
(B and C) RIPK3 expression level in various subsets of immune cells in (B) spleen and (C) colonic lamina propria of Ripk3-gfpfl/fl reporter mice was determined by
measuring the GFP fluorescence intensity using a flow cytometer (n = 2). CD19+ and CD3+ cells were defined as B and T cells, respectively. CD3CD19CD11c+
cells were defined as DCs, except for colonic CD3CD19CD11c+CD11b+ cells, which were defined as MNPs. CD3CD19CD11cCD11b+ cells were defined
as macrophages (Mf), except for the CD3CD19CD11cCD11bhiF4/80lo cells, which were defined as monocytes (Mo).
(D) Spleen was harvested from Ripk3+/+ (dashed line) and Ripk3-gfpfl/fl reporter mice (solid line) 15 hr after intraperitoneal injection of LPS (50 mg/mouse).
Representative histogram of GFP fluorescence intensity in CD11bhiF4/80lo monocytes is shown.
(E) Mean fluorescence intensity (MFI) of the GFP fluorescence in various colonic lamina propria mononuclear cells from DSS-treated Ripk3-gfpfl/fl reporter mice is
shown (n = 5–6).
(F) Representative histograms of the GFP fluorescence intensity in CD44hi or CD44lo splenic CD3+CD4+ or CD3+CD8+ T cells are shown.
(G) Splenocytes were stimulated with either anti-CD3 and anti-CD28 antibodies or concanavalin A (Con A) for 3 days. Representative FACS plots in CD3+CD4+ or
CD3+CD8+ T cells were shown.
Results shown are mean ± SEM. *p < 0.05. See also Figures S1 and S2.
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Real-time PCR analysis using various mouse tissues showed
the highest expression of the Ripk3 transcript in the spleen (Fig-
ure S2A), suggesting that RIPK3 is highly expressed in immune
cells. Indeed, strong GFP fluorescence signal was detected in
various immune cells in the spleen (Figure 1B; Figure S2B). In
particular, splenic CD11cCD11bhighF4/80low monocytes ex-
pressed RIPK3 at the highest level (Swirski et al., 2009) (Fig-
ure 1B). In contrast, CD11c+CD11b+CD103 MNPs, but not
CD11cCD11b+ macrophages, showed the highest RIPK3
expression in the colon (Figure 1C; Figure S2C). These results
indicate that RIPK3 expression pattern in immune cells is highly
variable in different cell types and tissues.
We next examined how inflammation might affect RIPK3
expression. To this end, we first injected lipopolysacharride
(LPS) intraperitoneally and analyzed splenocytes for RIPK3
expression. Whereas RIPK3 expression in CD11cCD11bhighF4/
80lowmonocytes was further enhanced (Figure 1D), no significant
change inGFPfluorescencewasobserved inother cell types (Fig-
ure S2D). Moreover, RIPK3 protein expression in multiple tissues
was unchanged despite clear induction of mature IL-1b (Fig-
ure S2E). We previously showed that RIPK3 expression was
increased in immune cells in the lamina propria of dextran sodium
sulfate (DSS)-treatedmice (Moriwaki et al., 2014). Consistentwith
our previous results, RIPK3-GFP expression in colonic CD3+
T cells, but not other immune cells, was significantly increased
uponDSS treatment (Figure 1E). In addition, higherRIPK3expres-
sion was found in splenic CD44hi effector-memory T cells
compared with CD44lo naive T cells (Figure 1F). In vitro activation
of T cells by anti-CD3andanti-CD28antibodiesor concanavalin A
(Con A) also enhanced RIPK3 expression (Figures 1G and S2F).
These results indicate that RIPK3 expression is highly inducible
in T cells.
The RIPK3 RHIM Is Critical for RIPK3-Mediated Cell
Death
RIPK3has twodistinct functional domains: thekinasedomainand
the RHIM. Studies in knock-in mice expressing kinase inactive
RIPK3 (Ripk3K51A/K51A and Ripk3D161N/D161N) showed that RIPK3
kinase activity is crucial for necroptosis (Mandal et al., 2014;
Newton et al., 2014). In contrast, the physiological function of
the RHIM has not been fully explored. To examine the physiolog-
ical importance of theRHIM,we generatedmice specifically lack-
ing RIPK3 RHIM at the C terminus using Cre-loxP-mediated
recombination (Figure S3A).Wecrossed theRipk3-gfpfl/fl reporter
mice with Sox2-Cre deletor mice to generate mice with germline
deletion of the RHIM (Ripk3DR/DR) (Figure S3B). Loss of GFP fluo-
rescence signal from all immune cell subsets from Ripk3DR/DR
mice was confirmed by flow cytometry (Figure 2A). Because the
stop codon of the Ripk3 gene was removed in the Ripk3DR allele,
we performed 30-rapid amplification of cDNA ends (RACE) exper-
iment using total RNA from Ripk3DR/DR MEFs to determine the
C-terminal amino acid sequence of the RIPK3-DRHIM protein.
The result revealed two possible mRNA transcripts generated
from the Ripk3DR allele (Figure S3C). DNA sequencing confirmed
that both transcripts are expected to encode truncated and
shorter RIPK3 that lack theRHIM (Figure S3D). Awidely used rab-
bit polyclonal antibody that recognizes the C-terminal end of
mouse RIPK3 revealed loss of full-length RIPK3 expression from
Ripk3DR/DR cells and tissues (Figures 2B and2C; Figure S3E,mid-
dle, RIPK3-P). In contrast, the anti-RIPK3 antibody clone 1G6.1.4
(RIPK3-G) recognized both wild-type RIPK3 and the RIPK3-
DRHIM proteins that were absent in Ripk3/ cells (Figures 2B
and 2C; Figure S3E, top, RIPK3-G) (Newton et al., 2014). It should
be noted that the RIPK3-G antibody detected two bands, both of
whichwere specific forRIPK3 (Newtonet al., 2014), and that a sin-
gle band of RIPK3-DRHIM protein was detected between these
two wild-type (WT) bands (Figures 2B and 2C). This suggests
that WT RIPK3 has two isoforms with different C-terminal se-
quences. Similar to mice expressing kinase inactive RIPK3 (Man-
dal et al., 2014), RIPK3-DRHIM was expressed at a lower level
compared with wild-type RIPK3 (Figures 2B and 2C, top). This
suggests that the RHIM and kinase activity are both required to
stabilize RIPK3 protein expression.
To evaluate the impact of the RHIM on necroptosis, we treated
Ripk3DR/DR MEFs with TNF, the pan-caspase inhibitor zVAD-fmk
(zVAD), and cycloheximide (CHX). In contrast with wild-type
MEFs,Ripk3DR/DRMEFswere resistant toTNF-inducednecropto-
sis (Figure 2D).Ripk3DR/DR BMDCswere also resistant to necrop-
tosis induced by LPS and zVAD-fmk (Figure 2E) and zVAD-fmk
and the Smac mimetic BV6 (Figure 2F), which induces autocrine
TNF production (McComb et al., 2012). In addition, Ripk3DR/DR
BMDMs were resistant to necroptosis induced by TNF, LPS, or
polyinosinic-polycytidylic acid (polyIC) in the presence of the
pan-caspase inhibitor zVAD-fmk (Figure 2G). Similar resistance
to necroptosis was observed in Ripk3/ 3T3 cells reconstituted
withHA-taggedRIPK3-DRHIMproteins (FigureS3F). By contrast,
Ripk3DR/DR BMDMs were equally sensitive to apoptosis induced
by TNF, LPS, or poly(I:C) (Figure S3G). Moreover, Ripk3DR/DR
MEFswere resistant to apoptosis inducedby theRIPK3kinase in-
hibitor GSK’843 (Figure S3H), which causes caspase-8 activation
through RHIM-mediated formation of the ripoptosome (Mandal
et al., 2014; Moriwaki and Chan, 2016). Furthermore, Ripk3DR/DR
BMDCs were resistant to LPS- and CHX-induced caspase-3/8
activation and apoptosis (Figures S3I and S3J) (Moriwaki et al.,
2015). These results indicate that the RIPK3 RHIM is crucial for
RIPK3-mediated necroptosis and apoptosis.
Caspase-8/ and Fadd/ mice suffer from embryonic
lethality caused by excessive necroptosis. This defect was
completely rescued by inactivation of RIPK3 (Kaiser et al., 2011;
Oberst et al., 2011). We set up intercrosses of Fadd+/Ripk3DR/DR
mice and found that Fadd/Ripk3DR/DR mice were born at a
Mendelian ratio (Figure 2H). Moreover, Fadd/Ripk3DR/DR mice
developed splenomegaly and lymphadenopathy (Figure 2I), and
exhibited an expansion of CD3+B220+CD4CD8 T cells in the
spleen (Figure 2J). These phenotypes are characteristic of lpr
and gld mice and the human autoimmune lymphoproliferative
syndrome (ALPS) (Lenardo et al., 1999). Hence, the RIPK3
RHIM is essential for necroptosis induced by various physiolog-
ical stimuli, and deletion of the RHIM is functionally equivalent to
the Ripk3 null allele.
The RHIM Is Essential for RIPK3-Dependent Cytokine
Production
We previously reported that RIPK3 promotes NF-kB and inflam-
masome activation in BMDCs, and that these necroptosis-inde-
pendent signaling functions are crucial for cytokine production
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downstream of TLR4 (Moriwaki et al., 2014). In contrast with
BMDCs treated with an RIPK3 kinase inhibitor (Moriwaki
et al., 2014), LPS-induced Il23p19 expression was reduced in
Ripk3DR/DR BMDCs (Figure 3A). TNF expression was also signif-
icantly diminished in LPS-treatedRipk3DR/DRBMDCs (Figure 3B).
The RelB-p50 heterodimer potently induces Il23p19 expression
by BMDCs in response to TLR stimulation (Shih et al., 2012).
This led us to test whether the RIPK3 RHIM is required for
optimal RelB-p50 activation and cytokine expression (Moriwaki
et al., 2014). Indeed, LPS-induced nuclear translocation of
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Figure 2. The RIPK3 RHIM Is Essential for Necroptosis
(A) Representative histograms of the GFP fluorescence in splenocytes of mice with indicated genotype are shown.
(B and C) Western blotting of (B) BMDCs and (C) Con A-activated T cell blasts frommice of the indicated genotypes was performed using two distinct anti-RIPK3
antibodies, RIPK3-P and RIPK3-G. The wild-type RIPK3 and RIPK3-DRHIM bands are indicated. Asterisks (*) indicate non-specific signals.
(D–G) Necroptosis was induced by various stimuli in (D) MEFs, (E and F) BMDCs, and (G) BMDMs from Ripk3+/+ and Ripk3DR/DR mice. L, 100 ng/mL LPS; N, no
stimulation; P, 20 mg/mL poly(I:C); T, 100 ng/mL TNF.
(H) Fadd+/Ripk3DR/DR mice were intercrossed, and the number of offspring with each genotype is shown.
(I) A representative picture of the spleen and lymph node in 13-week-old mice of the indicated genotypes is shown.
(J) Splenocytes from 13-week-old mice of the indicated genotypes were analyzed by flow cytometer.
Results shown are mean ± SEM of triplicates. See also Figure S3.
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RelB and p50 was similarly impaired in Ripk3DR/DR and Ripk3/
BMDCs (Figure 3C).
In monocytes and DCs, LPS alone is sufficient to stimulate
mature IL-1b secretion without a second inflammasome activa-
tion signal (He et al., 2013; Moriwaki et al., 2015). This response
requires an intact RIPK3, but not its kinase activity (Moriwaki
et al., 2015). LPS-induced IL-1b secretion was blunted in
Ripk3DR/DR BMDCs (Figure 3D), indicating that unlike the kinase
activity, the RHIM is essential for this function. Mature IL-1b
secretion is achieved by cleavage of pro-IL-1b by caspase-1 or
caspase-8 (Latz et al., 2013). The activation of both caspases
was equally impaired in Ripk3DR/DR and Ripk3/ BMDCs (Fig-
ures 3E and 3F). RIPK3 stimulates caspase-8-mediated cleav-
age of pro-IL-1b through a ripoptosome-like complex (Kang
et al., 2015; Lawlor et al., 2015; Moriwaki et al., 2015). Assembly
of this complex is enhanced by addition of GSK’843, which
causes a conformational change of RIPK3 to promote interaction
with RIPK1, FADD, and caspase-8 (Moriwaki et al., 2015).
GSK’843 enhanced LPS-induced caspase-8 activation and IL-
1b secretion inRipk3+/+BMDCs (Figures 3G and 3H). In contrast,
GSK’843 failed to stimulate IL-1b secretion or caspase-8 activa-
tion in Ripk3DR/DR BMDCs (Figures 3G and 3H). Hence, unlike its
kinase activity, the RIPK3 RHIM is essential for optimal LPS-
induced NF-kB and inflammasome activation.
The RHIM of RIPK3 Mediates Protection against
DSS-Induced Colitis
DSS induces intestinal epithelial cell injury, and the resultant
inflammation exhibits certain features resembling acute colitis.
We previously showed that RIPK3-mediated expression of the
cytokines IL-23, IL-1b, and IL-22 has a crucial role in the resolu-
tion of intestinal injury (Moriwaki et al., 2014). To determine
whether this tissue repair function of RIPK3 requires an intact
RHIM, we treated Ripk3DR/DR mice with DSS for 7 days, followed
by recovery in normal drinking water for another 7 days. When
compared with Ripk3+/+ littermates, Ripk3DR/DR mice suffered
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Figure 3. The RIPK3 RHIM Is Required for Cytokine Production in BMDCs
(A–H) Ripk3+/+, Ripk3/, and Ripk3DR/DR BMDCs were stimulated with LPS for 6 hr (A, B, D, and G), 2 hr (C), or 1 hr (E, F, and H). (F–H) Where indicated, the cells
were pretreated with GSK’843 for 1 hr. (A) Il23p19 expression was determined by Q-PCR (n = 3). (B, D, and G) TNF (B) and IL-1b (D and G) secretion were
determined by ELISA (n = 3–8). (F) Caspase-1 activity was quantified using fluorescent substrate YVAD-AFC (n = 2). (C, E, andH) Nuclear extracts (C) or whole-cell
lysates (E and H) were subjected to western blotting. Results shown are mean ± SEM. *p < 0.05.
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from more severe body weight loss (Figure 4A). In addition,
colon length after DSS treatment was significantly reduced
in Ripk3DR/DR mice (Figure 4B). In contrast, Ripk3kd/kd (K51A) ki-
nase inactive mice developed similar intestinal inflammation
comparedwith co-housedRipk3+/controls, inwhichRIPK3pro-
tein is expressed at the level similar to RIPK3 K51A protein, as
determined by body weight loss and colon length on day 15 (Fig-
ures 4Cand 4D). Because the kinase activity of RIPK3 is essential
for necroptosis, these results indicate thatRIPK3mediates repar-
ative inflammation in the intestine through RHIM-dependent, but
necroptosis- and kinase-independent, mechanisms.
RIPK3 Promotes Injury-Induced Cytokine Expression by
CD11c+ Cells
Radiation BM chimera experiments revealed that RIPK3 expres-
sion in hematopoietic cells was important for protection against
DSS-induced colitis (Moriwaki et al., 2014). Adoptive transfer of
LPS-treated Ripk3+/+ BMDCs, but not Ripk3/ BMDCs,
rescued production of the tissue-repair-associated cytokines
IL-22, IL-23, and IL-1b. Because RIPK3 promotes optimal cyto-
kine expression in BMDCs, we reasoned that DC-like cells are
responsible for the protective effect of RIPK3 in DSS-induced
colitis and tissue repair. To test our hypothesis, we generated
DC-specific Ripk3DR/DR (CD11c:Ripk3-gfpfl/fl) mice by crossing
the Ripk3-gfpfl/fl reporter mice with CD11c (Itgax)-Cre transgenic
mice. Flow cytometry confirmed that the GFP fluorescence
signal was lost in CD11c+ cells (Figure 5A). Consistent with the
reported weak activity of the CD11c-Cre transgene in T and B
cells (Caton et al., 2007), we also observed slight reduction in
GFP signals in these cells. When the CD11c:Ripk3-gfpfl/fl mice
were challenged with DSS, they exhibited much more severe
body weight loss and shortening of the colon than Ripk3-gfpfl/fl
littermates (Figures 5B and 5C). Similar to Ripk3/ mice (Mori-
waki et al., 2014), CD11c:Ripk3-gfpfl/fl mice produced signifi-
cantly reduced IL-22, a critical promoter of tissue repair, in the
colon after DSS treatment than littermate controls (Figure 5D).
In addition, expression of IL-23 and IL-1b, which stimulate
IL-22 production by type 3 innate lymphoid cells (Lee et al.,
2013), was also significantly suppressed in the colon of DSS-
treated CD11c:Ripk3-gfpfl/fl mice (Figure 5D). By contrast, TNF
expression, which was normal in DSS-treated Ripk3/ mice
(Moriwaki et al., 2014), was also unaffected in CD11c:Ripk3-
gfpfl/fl mice (Figure S4A). The number of T cells, B cells, and
CD11c+ and CD11b+ MNPs in the intestinal lamina propria was
similar in Ripk3-gfpfl/fl and CD11c:Ripk3-gfpfl/fl mice (Figures
S4B and S4C). In addition, the percentage of type 3 innate
lymphoid cells and RIPK3 in these cells was also unchanged in
CD11c:Ripk3-gfpfl/fl mice (Figures S4D and S4E). These results
are consistent with those observed in germline Ripk3/ mice
and indicate that RIPK3 promotes optimal expression of
repair-associated cytokines by CD11c+ cells in a cell-intrinsic
manner.
TheRole of ColonicCX3CR1
+MNPs inRIPK3-Dependent
Cytokine Expression
Colonic CD11c+ cells are subdivided into two main populations:
CD11c+CD11b+CD103 and CD11c+CD11bCD103+ cells (Fig-
ure S2C) (Denning et al., 2011). Whereas CD11c+CD11b
CD103+ cells are considered to be conventional DCs developed
from common DC precursors, CD11c+CD11b+CD103 cells are
developed from monocytes and express both DC and macro-
phage markers (Cerovic et al., 2014). Within the CD11c+CD11b+
CD103 MNPs, the chemokine receptor CX3CR1 was reported
to mark a population of cells that are the main source of IL-23
and IL-1b during intestinal inflammation (Longman et al., 2014).
We therefore tested the role of RIPK3 in cytokine production
by the CX3CR1
+ MNPs. Because no reliable CX3CR1 antibody
is available for flow cytometry, we used CD14 as a marker
to test RIPK3 expression in this population. Consistent with
a previous report (Diehl et al., 2013), we confirmed by using
Cx3cr1
gfp/+ reporter mice that the CD11c+MHC-II+CD14+
MNPs were indeed exclusively positive for CX3CR1 expression
(Figure S5A). Interestingly, these CD11c+CD11b+CD103CD14+
MNPs also expressed high levels of RIPK3 compared
with CD11c+CD11bCD103+ DCs (Figure 6A). We isolated
CX3CR1
+ MNPs and CD103+ DCs from colonic lamina propria
of untreated Ripk3+/+Cx3cr1gfp/+ and Ripk3/Cx3cr1gfp/+ mice
or the mice challenged with DSS for 7 days and compared their
cytokine expression profile (Figure S5B). Consistent with a pub-
lished report (Longman et al., 2014), Il23p19 and Il1b expression
were induced in CX3CR1
+ MNPs in response to DSS (Figure 6B).
In contrast, the cytokine expression was undetectable in CD103+
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Figure 4. The RIPK3 RHIM, but Not Its Kinase Activity, Mediates
Protection against DSS
(A–D)Ripk3DR/DR (n = 10) andRipk3+/+ littermates (n = 16) (A andB), orRipk3kd/kd
(n = 17) and Ripk3+/ co-housed mice (n = 14) (C and D) were treated with 3%
DSSfor7days, followedby regularwater foranadditional 7days. (AandC)Body
weight was measured daily. (B and D) Colon length was measured on day 15.
The inset in (C) shows equal RIPK3 protein expression between Ripk3kd/kd and
Ripk3+/ colon. Results shown are mean ± SEM. *p < 0.05.
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DCs (Figure 6B). Strikingly, the expression of Il23p19 was signif-
icantly reduced in CX3CR1
+ MNPs isolated from Ripk3/
Cx3cr1gfp/+ mice compared with those from Ripk3+/+Cx3cr1gfp/+
littermates. The expression of Il1bwas also reduced in CX3CR1
+
MNPs isolated from Ripk3/Cx3cr1gfp/+ mice, although the dif-
ference was not statistically significant. To determine whether
CX3CR1
+ MNPs are responsible for the impaired cytokine
expression in CD11c:Ripk3-gfpfl/fl mice, we isolated CD11c+
CD11b+CD14+ MNPs from DSS-treated Ripk3-gfpfl/fl and
CD11c:Ripk3-gfpfl/fl mice. Indeed, the cells from CD11c:Ripk3-
gfpfl/fl mice also exhibited reduction in Il1b and Il23p19 expres-
sion (Figure S5C), although the difference was not statistically
significant. Collectively, these results suggest that CX3CR1
+
MNPs in the lamina propria contribute to injury-induced cytokine
expression.
DISCUSSION
RIPK3 is a keysignal adaptor for necroptosis.Recently,RIPK3has
also been shown to promote activation of the NLRP3 inflamma-
some, NF-kB, and apoptosis. The role of RIPK3 in necroptosis-in-
dependent signaling isespeciallyprominent in innate immunesen-
tinels such as macrophages and DCs. However, tools that allow
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Figure 5. CD11c+ Cell-Specific Deletion
of the RIPK3 RHIM Confers Protection
against DSS
(A) Representative histograms of the GFP fluo-
rescence intensity in colonic lamina propria
mononuclear cells from mice of the indicated
genotypes are shown.
(B and C) Ripk3-gfpfl/fl (n = 11) and CD11c:Ripk3-
gfpfl/fl littermates (n = 16) were treated with 3%
DSS for 7 days, followed by regular water for an
additional 7 days. Body weight was measured
daily (B). Colon length on day 15 is shown (C).
(D) Expression of Il22, Il23p19, and Il1b in colon
from the mice treated with DSS for 7 days was
determined by qPCR (n = 3–10).
Results shown are mean ± SEM. *p < 0.05. See
also Figure S4.
examination of RIPK3 functions in distinct
cell populations have been lacking. In this
study, we report two mouse models that
address this deficiency. Using the RIPK3-
GFP reporter mice, we found that RIPK3
expression is dynamically regulated in
different immune subsets. For example,
RIPK3 expression was increased in mac-
rophages in response to LPS stimula-
tion. In contrast, RIPK3 expression was
strongly induced in T cells during intesti-
nal inflammation. T-cell-receptor-depen-
dent induction of RIPK3 expression
suggests that RIPK3 may regulate T cell
responsesand functions. Indeed,previous
studies showed thatFadd/Ripk3/ and
Casp8/Ripk3/mice developed an lpr/
gld-likeautoimmunedisease (Dillonet al., 2012;Kaiser etal., 2011;
Oberst et al., 2011), indicating that RIPK3 cooperates with FADD/
caspase-8 to enforce peripheral T cell tolerance. Whether RIPK3
regulates other functions in T cells is unknown at present.
In contrast with T cells, RIPK3 has a key role in cytokine
expression by DCs and macrophages. RIPK3 expression in
CD11c+ DCs and CD11b+ macrophages was not dramatically
altered during LPS- or DSS-induced inflammation, although its
expression in these innate immune effectors in different anatom-
ical locations is highly variable. For instance, CD11c+MHC-
II+CD11b+ MNPs in the colonic lamina propria highly expressed
RIPK3 compared with those in spleen and showed the highest
RIPK3 expression among various immune cell subsets. These
cells have been implicated to be major producers of IL-23 and
IL-1b, which in turn stimulate IL-22 production by type 3 innate
lymphoid cells (Aychek et al., 2015; Longman et al., 2014; Manta
et al., 2013). Depletion of this population or knockout of CX3CR1
exacerbated experimental colitis (Longman et al., 2014; Medina-
Contreras et al., 2011). Although some of the effect might be
because of the reduced expression of RIPK3-DRHIM protein,
deletion of the RIPK3 RHIM in CD11c+ cells alone was sufficient
to recapitulate the severe colitis observed in germline Ripk3/
mice. This observation strongly suggests that the RHIM is
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essential for necroptosis-dependent and -independent func-
tions of RIPK3. Ripk3/ CX3CR1
+ MNPs and CX3CR1
+ MNPs
from CD11c:Ripk3-gfpfl/fl mice produced reduced levels of
Il-1b, Il23p19, and Il22, although the differences were not always
statistically significant. Thus, there may be other immune effec-
tors within the lamina propria that require RIPK3 to achieve
optimal cytokine expression.
RIPK3 is widely believed to induce inflammation through nec-
roptosis-associated release of damage-associated molecular
patterns (Kaczmarek et al., 2013). This current dogma is mostly
based on studies from mice lacking caspase-8 or FADD, or mul-
tiple cellular inhibitor of apoptosis proteins (cIAPs), all of which
are strong inhibitors of RIPK3 pro-necroptotic function (Chan
et al., 2015). It is therefore striking that unlike Ripk3DR/DR or
Cd11c-Cre:Ripk3-gfpfl/fl mice, Ripk3kd/kd mice did not develop
more severe colitis. Thus, in injury-induced cytokine expression
and tissue repair, RIPK3 functions exclusively as an inducer of
cytokine expression rather than as a cell death adaptor. A nec-
roptosis-independent role for RIPK3 in NLRP3 inflammasome
activation has been observed in in vitro studies with BMDMs
and BMDCs (Kang et al., 2015; Lawlor et al., 2015; Moriwaki
et al., 2015; Vince et al., 2012). However, as in the case of nec-
roptosis, maximal RIPK3-mediated inflammasome activation
also requires FADD, caspase-8, or cIAPs inhibition. Thus, our
result demonstrates a necroptosis-independent role for RIPK3
in physiological inflammation without pharmacological or ge-
netic manipulation of FADD, caspase-8, or cIAPs. Our results
also reveal that the non-necroptotic functions of RIPK3 may be
confined to specific cell compartments. In this scenario, its
function can only be revealed using tissue-specific inactivation
approaches.
We previously reported that the RIPK3-RIPK1-FADD-cas-
pase-8 complex was formed upon LPS stimulation in BMDCs.
Assembly of this ripoptosome-like complex also requires
another RHIM-containing adaptor TRIF (Moriwaki et al., 2015).
Results from this present study indicate that an intact RHIM is
not only crucial for necroptosis, but also for RIPK3-dependent ri-
poptosome assembly and pro-IL-1b processing. However, this
function of RIPK3 does not require its pro-necroptotic kinase ac-
tivity. In contrast, the mechanism by which RIPK3 promotes
RelB-p50 activation is less understood. RIPK3 has been impli-
cated to shuttle between the cytoplasm and nucleus (Yang
et al., 2004; Yoon et al., 2016), suggesting that RIPK3 may
directly engage the transcriptional machinery under certain
conditions.
EXPERIMENTAL PROCEDURES
Mice
To generate Ripk3-gfpfl/fl reporter mice, we created a targeting construct in
which an eGfp sequence was inserted at the end of the coding region of the
Ripk3 gene. The neomycin resistance gene flanked by flippase recognition
target (FRT) sites was inserted in intron 9 for positive selection. For negative
selection, thymidine kinase was added outside the 50 homology arm. LoxP
sites were also inserted before the neomycin cassette and after the EGFP
sequence. Embryonic stem (ES) cells were transfected with the targeting
construct and subsequently selected by neomycin in the transgenic animal
core at the University of Massachusetts Medical School (UMMS). ES clones
in which proper recombination occurs were selected by Southern blot anal-
ysis, with probe 1 located in the 50 homology arm and probe 2 located outside
the 30 homology arm and subsequently used for injection into albino C57BL/6
blastocysts to generate chimeric mice. Germline transmission of the trans-
gene was confirmed by Southern blot analysis. The neomycin cassette was
removed by crossing the Ripk3-gfpflox-neo/+ mice with the flippase transgenic
mice [Gt(ROSA)26Sortm1(Flp1)Dym, kindly provided from S. Jones in UMMS].
To generate mice constitutively deficient for the Ripk3 RHIM, we crossed
Ripk3-gfpflox-neo/+ mice with Sox2-Cre transgenic mice (kindly provided from
S. Jones in UMMS). The resultant Ripk3fl/+ and Ripk3DRHIM/+ mice were back-
crossed with C57BL/6 mice for 8–10 generations. To delete the RHIM specif-
ically in CD11c+ cells, we crossed Ripk3-gfpfl/fl mice with CD11c (Itgax)-Cre
transgenic mice obtained from The Jackson Laboratory. Ripk3/ mice were
obtained from Genentech. Fadd/ mice were described before (Zhang
et al., 2011). Ripk3 K51A kinase dead knock-in (Ripk3kd/kd) mice were gener-
ated in GlaxoSmithKline (Mandal et al., 2014). Cx3cr1gfp/gfp reporter mice
were obtained from The Jackson Laboratory. All animal experiments were
approved by the institutional animal care and use committee. The RIP3-GFP
floxed mice are available at The Jackson Laboratory as Stock No. 030284.
DSS Treatment
Female mice (9–12 weeks old) were treated with 3% DSS (molecular mass
36,000–50,000 Da; MP Biomedicals) for 7 days. The DSS water was replaced
with fresh DSS water on days 3 and 5 and with regular water on day 8. Body
weightwasmonitored for 15days, and theweight at the beginning of the exper-
iments was normalized as 100%. To obtain Ripk3+/ control mice with a mini-
mum difference of genetic background, we crossed Ripk3kd/+ mice with
Ripk3/ mice. The resultant Ripk3kd/ or Ripk3+/ mice were intercrossed to
obtain Ripk3kd/kd or Ripk3+/mice. After weaning, these mice were co-housed
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Figure 6. RIPK3 Promotes Cytokine Pro-
duction by Colonic CX3CR1
+ MNPs
(A) Mononuclear cells from untreated or DSS-
treated Ripk3-gfpfl/fl and Ripk3+/+ mice were
analyzed for RIPK3-GFP mean fluorescence in-
tensity (MFI). CD14+ MNPs and CD103+ DCs were
defined as CD45+CD3CD19CD11c+MHC-II+
CD14+CD103 (for CD14+MNPs) andCD45+CD3
CD19CD11c+MHC-II+CD14CD103+ (for CD103+
DCs), respectively (n = 5–6).
(B) CD45+CD11c+MHC-II+CD11b+CX3CR1
+ MNPs
and CD45+CD11c+MHC-II+CD11bCD103+ DCs
were FACS-sorted from mice treated with DSS for
7 days and subjected to RNA extraction and qPCR
analysis (n = 2–6).
Results shown are mean ± SEM. *p < 0.05. See
also Figure S5.
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to minimize the influence of intestinal microflora. All experiments, except for
the ones using Ripk3kd/kdmice, were performed using littermates. To minimize
the differences in intestinal microbial environment among cages, we mixed
bedding materials from different cages once a week after weaning.
Flow Cytometry
Colonwas harvested from untreated or DSS-treatedmice. After removing feces
with PBS, the colonwas longitudinally openedand cut into three pieces. The tis-
sueswerewashedwithPBSandsubsequently incubated in1mMDTT for 10min
at roomtemperature (RT). Then, the tissueswere shaken in 10mMHEPESbuffer
containing 30mMEDTA for 10min at 37C (225 rpm). After washing, the tissues
were digested with 0.5 mg/mL collagenase IV (Sigma) and 150 mg/mL DNase I
(Sigma) for 90min at 37C. Tissues were broken by vigorously shaking, filtered,
andsubjected toPercoll densitygradient separation. LPMCsat the interphaseof
the two Percoll solutions were collected and subjected to flow cytometric anal-
ysis. To isolate splenocytes, we incubated spleen with 2 mg/mL collagenase D
solution (10mMHEPES [pH7.4], 150mMNaCl, 5mMKCl, 1mMMgCl2, 1.8mM
CaCl2) for 30minat 37
C.After gliding the spleen, redbloodcellswere lysedwith
ACK lysis buffer (150 mM NH4Cl, 10 mM KHCO3, 0.1 mM EDTA). Splenocytes
were filtered and subjected to flow cytometric analysis. Prior to incubation
with primary antibodies, cells were incubated with anti-Fc receptor 2.4G2 anti-
body for 10 min. PE-labeled anti-CD3 (145-2C11), PerCP-Cy5.5-labeled anti-
CD11b (M1/70), Pacific blue-labeled anti-F4/80 (BM8), Pacific blue-labeled
anti-CD45.2 (104), biotin-labeled CD103 (2E7), PerCP-Cy5.5-labeled anti-
CD8b (YTS/56.7.7), and PE-labeled anti-MHCII I-Ab (AF6-120.1) antibodies
were obtained from BioLegend. PE-Cy7-labeled CD19 (eBio10-3), PE-Cy7-
labeled CD44 (IM7), PE-Cy7-labeled anti-CD14 (Sa2-8) antibodies, and
allophycocyanin (APC)-eFluor780-labeled streptavidin were obtained from
eBioscience. APC-labeled anti-CD11c (HL3), APC-Cy7-labeled anti-CD8a
(53-6.7), APC-labeled anti-CD3 (145-2C11), APC-Cy7-labeled anti-CD4
(GK1.5), FITC-labeled anti-CD19 (1D3), PE-labeled anti-B220 (RA3-6B2), Alexa
Fluor 647-labeled CCR6 (140706), PE-labeled Ter119 (TER-119), and Pacific
blue-labeled anti-CD4 (RM4-5) antibodies were obtained from BDBiosciences.
Cells were analyzed by LSRII (BD Biosciences). For cell sorting, FACSAria II
(BD Biosciences) was used.
T Cell Stimulation
A 24-well tissue culture plate was coated with 10 mg/mL anti-CD3 (145-2C11)
and 5 mg/mL anti-CD28 (37.51) antibodies at 4C overnight. Splenocytes were
plated onto the coated plate. For Con A stimulation, splenocytes were plated
onto uncoated plate and stimulated with 5 mg/mL Con A. After 3 days, the cells
were subjected to flow cytometric analysis.
Western Blot
Cell lysates prepared using radio-immunoprecipitation assay (RIPA) lysis buffer
supplemented with protease (Roche) and phosphatase inhibitors (Sigma) were
subjected to SDS-PAGE. Nuclear extracts were prepared as described before
(Moriwaki et al., 2014). After transferring proteins to nitrocellulose membrane,
immunoblot analysis was performed with the following antibodies: anti-RIPK3
(2283, RIPK3-P; Prosci), anti-mouse RIPK3 (clone 1G6.1.4, RIPK3-G; Genen-
tech), anti-HSP90 (68/Hsp90; BD Biosciences), anti-HA, anti-RelB (C1E4; Cell
Signaling), anti-p50 (H-119; Santa Cruz), anti-BRG1 (kindly provided by A.
Imbalzano), anti-caspase-8 (1G12; Enzo Lifesciences), anti-pro-IL-1b (AF-
401-NA; R&D Systems), and anti-caspase-3 (46; Santa Cruz) antibodies.
Cell Culture and Stimulation
BM cells were cultured for 7 days in either RPMI media supplemented with
10 ng/mL GM-CSF and 5 ng/mL IL-4 to generate BMDCs or L929-conditioned
media to generate BMDMs (Moriwaki et al., 2014). Ripk3+/+, Ripk3/,
Ripk3DR/DRMEFs,Ripk3/ 3T3, and 293T cells were cultured in DMEMmedia.
Ten percent fetal calf serum, 2mMglutamine, 100 U/mL penicillin, and 100 mg/
mL streptomycin were added to the media. Purified LPS from Invivogen was
used for all experiments. In some experiments, cells were pretreated with
zVAD-fmk (Enzo Lifesciences), CHX (Sigma), BV6 (kindly provided from D. Vu-
cic in Genentech), and/or RIPK3 kinase inhibitor GSK2393843A (GSK’843;
GlaxoSmithKline) for an hour prior to LPS, TNF, or polyIC stimulation, unless
otherwise stated. After stimulation, culture media and cells were used for
cell death assay, ELISA, RNA, and protein analyses. Caspase-1 activity was
measured by caspase-1 substrate YVAD-7-amido-4-trifluoromethylcoumarin
(YVAD-AFC) (BioVision).
qPCR
Total RNA was extracted from cells and tissues using RNeasy Mini kit
(QIAGEN) and subjected to reverse transcription using Superscript III (Invitro-
gen). Real-time PCR analysis using iQ SYBR Green Supermix (Bio-Rad Labo-
ratories) was performed on C1000 thermal cycler and CFX96 real-time system
(Bio-Rad laboratories). The following primers were used: 50-TTGAGGTGTCCA
ACTTCCAGCA-30 and 50-AGCCGGACATCTGTGTTGTTA-30 for Il22, 50-CCAG
CGGGACATATGAATCT-30 and 50-AGGCTCCCCTTTGAAGATGT-30 for Il23a
(Il23p19), 50-CCCAACTGGTACATCAGCAC-30 and 50-TCTGCTCATTCACGAA
AAGG-30 for Il1b, 50-TGTCAAGTTATGGCCTACTGGTGCG-30 and 50-AACCAT
AGCCTTCACCTCCCAGGAT-30 for Ripk3, and 50-CAAACCCAGAATTGTTCT
CCTT-30 and 50-ATGTGGTCTTCCTGAATCCCT-30 for Tbp.
Cell Death Assay
Cell death was determined by CellTiter-Glo Luminescent Cell Viability Assay
(Promega), CytoTox 96 Non-Radioactive Cytotoxicity Assay (Promega), or
CellTiter 96 AQueous One Solution Cell Proliferation Assay (Promega). All cell
death assays were performed in triplicates.
30-RACE PCR
DNA sequence of the 30 region of Ripk3DR mRNA was determined by 30-RACE
experiment (Scotto-Lavino et al., 2006). Total RNA was extracted from
Ripk3DR/DR MEFs and reverse transcribed using Qtotal primer (50-CCAGTGAG
CAGAGTGACGAGGACTCGAGCTCAAGCTTTTTTTTTTTTTTTTT-30) and Su-
perscript III. First PCRwas performed using Qouter primer (50-CCAGTGAGCAG
AGTGACG-30) and gene-specific primer (GSP) 1 (50-TGCTGCTGTCTCCGAG
GTAAAG-30). PCR product was subjected to second PCR using Qinner primer
(50-ATCGGATCCGAGGACTCGAGCTCAAGC-30 ) and GSP2 (50-ATCGAATTC
CAAAGGAATCAGGGAGATGGAAG-30). Pfu Turbo DNA polymerase AD was
used for PCR. PCR product was run on a 1% agarose gel and purified from
the gel. The purified products were digested by EcoRI and HindIII, and subse-
quently cloned into pUC19 vector. DNA sequence was determined by
sequence analysis.
Plasmids, Viruses, Transfections, and Transductions
Mouse wild-typeRipk3 gene andRipk3DR short and long isoforms were cloned
into a modified lentiviral tet-on pTRIPZ/Puro vector. HA tag was introduced at
the amino terminus of RIPK3 by PCR cloning. The sequence of all the genes
inserted was confirmed by sequence analysis. Ripk3/ 3T3 cells were trans-
duced by lentivirus generated in 293T cells with pTRIPZ, pMD2.G, and psPAX2
vectors. After transduction, the cells were selected by 2 mg/mL puromycin.
Statistical Analysis
The p values were calculated using unpaired t test with Welch’s correction or
two-way repeated-measures ANOVA. The p values <0.05 were considered
statistically significant.
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